Jefferies Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$794K Sell
5,700
-21,700
-79% -$3.04M 0.01% 1011
2025
Q4
$3.36M Hold
27,400
0.02% 609
2025
Q3
$3.04M Buy
+27,400
New +$3.11M 0.01% 507
2025
Q1
Sell
-33,000
Closed -$3.05M 1759
2024
Q4
$3.05M Sell
33,000
-31,800
-49% -$2.86M 0.02% 523
2024
Q3
$5.43M Hold
64,800
0.04% 299
2024
Q2
$4.45M Buy
64,800
+7,500
+13% +$501K 0.05% 332
2024
Q1
$4.2M Sell
57,300
-9,000
-14% -$692K 0.04% 352
2023
Q4
$5.37M Sell
66,300
-72,000
-52% -$5.6M 0.04% 378
2023
Q3
$10.4M Buy
138,300
+79,800
+136% +$6.14M 0.09% 160
2023
Q2
$4.51M Buy
58,500
+3,500
+6% +$279K 0.04% 390
2023
Q1
$4.56M Sell
55,000
-24,300
-31% -$2.01M 0.04% 393
2022
Q4
$6.81M Buy
+79,300
New +$6.28M 0.05% 313

Other funds holding GILD

Jefferies Financial Group's GILD Position: Q1 2026 in Review

Jefferies Financial Group reduced its Gilead Sciences (GILD) stake by 45% in Q1 2026, selling an estimated $10.3M and leaving 89,485 shares worth $12.5M. The position accounts for 0.09% of the portfolio, ranked #185.

Jefferies Financial Group first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $35.3M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Jefferies Financial Group held 89,485 shares of Gilead Sciences worth $12.5M as of Q1 2026.
  • Jefferies Financial Group sold 73,906 Gilead Sciences shares in Q1 2026, an estimated $10.3M.
  • Gilead Sciences made up 0.09% of Jefferies Financial Group's portfolio in Q1 2026, its #185 holding.
  • Jefferies Financial Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Gilead Sciences position peaked at $35.3M in Q1 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.